Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does GENTAMICIN Cause Intentional product use issue? 19 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 19 reports of Intentional product use issue have been filed in association with GENTAMICIN (Gentamicin). This represents 0.3% of all adverse event reports for GENTAMICIN.

19
Reports of Intentional product use issue with GENTAMICIN
0.3%
of all GENTAMICIN reports
1
Deaths
8
Hospitalizations

How Dangerous Is Intentional product use issue From GENTAMICIN?

Of the 19 reports, 1 (5.3%) resulted in death, 8 (42.1%) required hospitalization, and 1 (5.3%) were considered life-threatening.

Is Intentional product use issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for GENTAMICIN. However, 19 reports have been filed with the FAERS database.

What Other Side Effects Does GENTAMICIN Cause?

Acute kidney injury (1,026) Drug ineffective (824) Off label use (363) Maternal exposure during pregnancy (360) Foetal exposure during pregnancy (324) Premature baby (315) Product use in unapproved indication (313) Pyrexia (302) Premature delivery (283) Condition aggravated (252)

What Other Drugs Cause Intentional product use issue?

INFLIXIMAB (11,028) RITUXIMAB (9,602) INFLIXIMAB-DYYB (7,549) TOCILIZUMAB (5,078) METHOTREXATE (4,087) PREDNISONE (3,961) ABATACEPT (3,693) ADALIMUMAB (3,557) NIVOLUMAB (3,297) LEFLUNOMIDE (3,280)

Which GENTAMICIN Alternatives Have Lower Intentional product use issue Risk?

GENTAMICIN vs GEODON GENTAMICIN vs GIANVI GENTAMICIN vs GILENYA GENTAMICIN vs GILOTRIF GENTAMICIN vs GILTERITINIB

Related Pages

GENTAMICIN Full Profile All Intentional product use issue Reports All Drugs Causing Intentional product use issue GENTAMICIN Demographics